| Financial Year |
March 31 2023 |
| Monetary Funds |
1,075,096,591.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
70,493,042.45 |
| Accounts Receivable |
275,764,722.70 |
| Advances to Suppliers |
12,532,656.08 |
| Other Receivables |
14,957,983.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
145,562,329.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
45,735,779.42 |
| Total Current Assets |
1,664,328,874.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
132,384,120.62 |
| Under-construction Projects |
648,273,574.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,176,678.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,503,716.01 |
| Deferred Income Tax Assets |
18,253,537.04 |
| Other Non-Current Assets |
5,143,034.64 |
| Sub-Total of Non-Current Assets |
859,631,701.31 |
| Total Assets |
2,523,960,575.59 |
| Short-Term Loans |
80,025,777.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
79,394,873.42 |
| Accounts Payable |
130,197,381.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,169,945.11 |
| Taxes Payable |
8,058,438.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,636,891.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
910,006.95 |
| Other Current Liabilities |
107,130.97 |
| Sub-Total of Current Liabilities |
307,512,121.82 |
| Long-term Loans |
67,408,197.28 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
474,260.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,599,654.86 |
| Total Liabilities |
390,111,776.68 |
| Paid-In Capital(Or Share Stock) |
200,000,000.00 |
| Capital Surplus |
1,437,237,409.81 |
| Surplus Reserve |
74,159,599.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
383,698,517.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,133,848,798.91 |
| Owner's Equity（Stockholder's Equity） |
2,133,848,798.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,523,960,575.59 |
